Related Experiment Video
Updated: Jun 17, 2025

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
37.3K
Genetically predicted small dense low-density lipoprotein cholesterol and ischemic stroke subtype: multivariable
Xiao Yu1, Guangxun Shen1, Yan Zhang1
1China-Japan Union Hospital of Jilin University, Jilin University, Jilin, China.
Frontiers in Endocrinology
|August 13, 2024
Summary
Small dense low-density lipoprotein cholesterol (S-LDL-C) is causally linked to large artery stroke (LAS). This Mendelian randomization study confirms S-LDL-C
Area of Science:
- Cardiovascular Genetics
- Stroke Etiology
- Lipid Metabolism
Background:
- Small dense low-density lipoprotein cholesterol (S-LDL-C) is implicated in atherosclerosis.
- Causal links between S-LDL-C and specific ischemic stroke (IS) subtypes are not well-established.
- Understanding LDL subfractions' roles is crucial for IS prevention.
Purpose of the Study:
- To investigate the causal effects of S-LDL-C, medium (M-LDL-C), and large (L-LDL-C) subfractions on ischemic stroke (IS) risk.
- To analyze these effects across main IS etiological subtypes.
- To employ a two-sample Mendelian randomization (TSMR) design for robust causal inference.
Main Methods:
- Utilized genetic instruments for LDL subfractions from UK Biobank (n=115,082).
- Obtained summary-level data for ischemic stroke subtypes from the MEGASTROKE consortium.
- Conducted multivariable TSMR, adjusting for potential pleiotropic effects of triglycerides (TG) and HDL-C.
Main Results:
- A significant causal association was found between genetically predicted S-LDL-C and large artery stroke (LAS) (OR=1.481, P=0.006).
- No significant causal effects were observed for M-LDL-C or L-LDL-C on IS or its subtypes.
- The causal link between S-LDL-C and LAS remained significant in multivariable analysis (OR=1.329, P=0.002).
Conclusions:
- Findings provide genetic evidence supporting a causal role of S-LDL-C in large artery stroke (LAS).
- Further research is needed to clarify the underlying mechanisms.
- Clinical implications for targeting S-LDL-C in LAS prevention warrant investigation.
Keywords:
Mendelian randomizationischemic stroke (IS)large artery stroke (LAS)low-density lipoprotein cholesterol (LDL-C)low-density lipoprotein cholesterol (LDL-C) subfractionsmedium low-density lipoprotein cholesterol (M-LDL-C)small low-density lipoprotein cholesterol (S-LDL-C)
